A Randomized, Parallel Group, Open Label, Active Controlled Clinical Study to Evaluate the Efficacy and Safety of a Unani Formulation ? Qur?-i Sa‘fa (T) in the management of Qub ? (Tinea Corporis and Tinea Cruris). - N/A

ational Research Institute Of Unani Medicine For Skin Disorders0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年11月13日

试验速览

暂无简介。

•1. Participants of Qub ? (Tinea corporis and Tinea cruris) having circumscribed lesions with any of the following signs and symptoms on body and limbs:
•A)Presence of pruritus and burning
•B)Presence of scales
•C)Presence of central clearing
•D)Erythematous papules
•2. Participants with Positive KOH (10%) Smear Microscopy of Skin Scrapping from the active lesion for Dermatophytic hyphae.

•The following patients will be excluded:
•1) Age below 18 years and above 50 years
•2) Patients with other form of tinea infection like tinea pedis, tinea manuum, tinea unguium, tinea faciei, etc.
•3) Patient with other concomitant diseases like psoriasis & eczema
•4) Patients who have received any topical antifungal therapy within last 2 weeks or oral antifungal therapy in the previous 4 weeks
•5) Patients with known active pulmonary/ cardiovascular/ liver/ renal or neurological diseases
•6) Known cases of Diabetes Mellitus or other immunocompromised disorders (HIV/ AIDS, etc.)/ Malignancies
•7) Patients with long-term history of steroid, cytotoxic and immunosuppressive therapy
•8) History of hypersensitivity to either clotrimazole or Qur?-i Sa‘fa
•9) Pregnant or lactating women, and women desiring pregnancy
•10) Participants not willing to give consent and to attend treatment schedule regularly.

发起方

ational Research Institute Of Unani Medicine For Skin Disorders